CareDx Completes Allenex Acquisition
Expands Product Offerings to Support Transplant Patients
BRISBANE, CA, April 14, 2016: CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for transplant patients, today announced the completion of its previously announced acquisition of Allenex AB.
The combination of CareDx and Allenex creates an international transplant diagnostics company with product offerings focused on transplantation. The combined organization will have a direct presence in the United States and Europe supported by a broad global distributor network.
Meet us at EFI
Olerup will exhibit its bench mark products during the EFI meeting at Kos, Greece, starting on May 11.